Blood glucose trials, Blood sugar studies, Gluco x

This is a study that compares the performance of Gluco X (a generic name and not a commercial name), a herbal supplement product that is primarily made up of Gymnema, Bitter Melon, Salacia, Fenugreek, Jambolan and Cinnamon (active ingredients) and a conventional drug used for blood sugar management.* The following glucose trials were conducted for a total of 6 months using the Gluco X product and a control group taking a conventional drug. Both groups are made to follow the same dietary guidelines.

As the Table-3 (Moderately Diabetic) below shows, when a convention drug is used the fasting Blood Glucose levels came down by 26% in 3 months and by 38% in 6 months in the control group of 14 people. - For the group of 17 that were given the Gluco X product, the blood Glucose levels came down by 20% in 3 months and by 24% in 6 months approximately.*

As the Table-4 (Highly Diabetic) below shows when the convention drug is used the fasting Blood Glucose levels came down by 20% in 3 months and by 40% in 6 months in the control group of 14 people. - For the group of 17 that were given the Gluco X product, the blood Glucose levels came down by 16% in 3 months and by 31% in 6 months approximately.*

In conclusion the glucose trials study shows that the Gluco X product is more successful in managing blood sugar in people that are moderately Diabetic than ones that are highly Diabetic. The product works naturally helping blood sugar levels,* but does not match conventional drugs. The advantage is that Gluco X as a product does not have any side effects,* Again, all these trials are done on small controlled groups and may not be representative of all groups or people.*

*The above glucose trials study is for educational purposes only and it should not be construed as medical advise. Diabetes / High blood sugar is a serious medical condition and only your Medical Doctor can advise you on this and on other health matters. Please consult one.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

EVALUATION OF Gluco X IN THE MANAGEMENT OF TYPE-II DIABETES MELLITUS. Conducted under joint collaborative program. Centre of Psychosomatic & Biofeedback Medicine Institute of Medical Sciences Banaras Hindu University

Table-3: Decline in fasting blood glucose level following Gluco X
Response in Type-II Diabetis Mellitus casesr
Groups Num Cases Fasting Initial Blood Glucose Level Comps Initial vs > 6 monthsr
After 3 monthsr
After 6 months

Conventional drug + Dietary regulation 14 142.73rn±9.62_j 104.70rn±7.02 87.34rn±7.56 T=16.9
P<0.001
Given Gluco X + Dietary regulation 17 146.95 1rn±11.11 118.32rn±9-60 112.73rn±968 T=9.57
P<0,001
Normal range: 70-110 mg/DL

Table-4: Reduction in postprandial blood glucose level following Gluco X
Response in Type-II Diabetes Mellitus casesr
Groups Num Cases Blood Glucose Levelr
Comps Initial vs > 6 monthsr
Initial After 3 monthsr
After 6 months

Conventional drug + Dietary regulation 14 249.62rn±20.15 174.11rn±16.32 148.95rn±11.62 T=16.19
PO.001
Given Gluco X + Dietary regulation 17 252.71rn±18.35 212.65rn±14.03 173.31rn±8.75 T=16.10
PO.001
Postprandial Normal range: <140 mg/dl